Independent signal analyses using the project's standard disproportionality methodology.
2026-07-14
The FDA's Adverse Event Monitoring System, the quarterly public data behind our analyses, and why the strongest raw 'signal' is usually an artifact — not a discovery.
2026-06-13
The categories of adverse event the French biostatistician flagged in Pfizer's Comirnaty trial — cardiac, reproductive/menstrual, thrombotic, stroke — tested against the VAERS signal database with the project's 4-method consensus filter.
2026-05-12
Cardiac, neurological, and thrombotic signals in VAERS for nine COVID-19 vaccines and three shingles products — applied with the project's standard 4-method consensus filter.
2026-05-04
Bayesian disproportionality analysis across nine vaccine products — TTS, myocarditis, neurological, and allergic signals with first-detection dates.